Abstract
A radiopharmaceutical is a radioactive compound used for the diagnosis and therapeutic treatment of human diseases. In nuclear medicine nearly 95% of the radiopharmaceuticals are used for diagnostic purposes, while the rest are used for therapeutic treatment. Radiopharmaceuticals usually have minimal pharmacologic effect, because in most cases they are used in tracer quantities. Therapeutic radiopharmaceuticals can cause tissue damage by radiation. Because they are administered to humans, they should be sterile and pyrogen free, and should undergo all quality control measures required of a conventional drug. A radiopharmaceutical may be a radioactive element such as 133Xe, or a labeled compound such as 131I-iodinated proteins and 99mTc-labeled compounds.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Suggested Reading
Clark MJ, Podbielski L. Medical diagnostic imaging with complexes of Tc-99m. Coord Chem Rev. 1987; 78:253.
Deutsch E, Nicolini M, Wagner HN, Jr eds. Technetium in Chemistry and Nuclear Medicine. Verona: Cortina International; 1983.
Dewanjee MK. The chemistry of 99mTc-labeled radiopharmaceuticals. Semin Nucl Med. 1990; 20:5.
Dewanjee MK. Radioiodination: Theory, Practice and Biomedical Application. Boston: Kluwer Academic; 1992.
Eckelman WC, Steigman J, Paik CH. Radiopharmaceutical chemistry. In: Harpert J, Eckelman WC, Neumann RD, eds. Nuclear Medicine: Diagnosis and Therapy. New York: Thieme Medical; 1996:213.
Jones AG, Davison A. The relevance of basic technetium chemistry to nuclear medicine. J Nucl Med. 1982; 23:1041.
Nicolini M, Bandoli G, Mazzi U, eds. Technetium in Chemistry and Nuclear Medicine. Verona: Cortina International; 1986.
Richards P, Steigman J. Chemistry of technetium as applied to radiopharmaceuticals. In: Subramanian G, Rhodes BA, Cooper JF, Sodd VJ, eds. Radiopharmaceuticals. New York: Society of Nuclear Medicine; 1975:23.
Srivastava SC, Meinken G, Smith TD, Richards P. Problems associated with stannous 99mTc-radiopharmaceutical. In: Welch MJ, ed. Radiopharmaceuticals and Other Compounds Labelled with Short-Lived Radionuclides. New York: Pergamon Press; 1977:83.
Steigman J, Eckelman WC. The Chemistry of Technetium in Medicine. Nuclear Medicine Series. NAS-NS-3204. Washington: National Head Press; 1992.
Wilbur DS, Hadley SW, Hylarides MD, et al. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. J Nucl Med. 1989; 30:216.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Saha, G.B. (2010). Radiopharmaceuticals and Methods of Radiolabeling. In: Fundamentals of Nuclear Pharmacy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5860-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5860-0_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5859-4
Online ISBN: 978-1-4419-5860-0
eBook Packages: MedicineMedicine (R0)